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Abstract
The development and extensive spread of multi-drug resistant bacteria are 
considered as a major public health concern. Failures to control severe infections 
due to antibiotic resistance have augmented healthcare costs as well as patient 
morbidity and mortality. Presently, natural product-based therapeutics are gaining 
significant attention both for their antimicrobial effectiveness and for not persuad-
ing drug resistance. Furthermore, recent developments in nanoscience on new drug 
delivery systems built on nanostructured materials from plants and microbes have 
emerged which focus on targeted delivery and controlled release of therapeutic 
agents. This review examines the recent investigations on the biological activities 
of plant and bacterial biological material for silver nanoparticle (AgNP) synthesis. 
Also, the underlying mechanism of antimicrobial activities of silver nanoparticles 
against human pathogens will be discussed. A fact of the biological activities and/or 
chemical responses of plants is required, not only for the discovery of new thera-
peutic agents, but because such evidence may be of value in disclosing new sources 
of already known biologically active compounds.
Keywords: antimicrobial resistance, biological activities, drug delivery,  
green synthesis, health, silver nanoparticles
1. Introduction
The antimicrobial potential of silver (Ag) and Ag-based solutions has long been 
established, however, their application was considered obsolete upon the discovery 
of antibiotics [1, 2]. In recent years, the developing crisis of multi-drug resistant 
pathogenic infections has led to the resurgence in this metal, however, with the use 
of nanotechnology to generate its nanoparticle form. For this reason, tremendous 
efforts have been extended in nanotechnology, particularly in the development of 
green synthetic strategies for silver nanoparticle (AgNPs) production to facilitate 
their use in antimicrobial therapeutic applications [3].
The interest in silver nanoparticles (AgNPs) as an alternative to current antibiot-
ics has increased profoundly over the last few years. This is owed to the cumulative 
incidence of microbial drug-resistant infections and the lack of appropriate treat-
ment thereof [4]. The World Health Organisation report of 2014 highlighted the 
probability of a post-antibiotic era in which common infections and minor injuries 
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could potentially result in fatalities [5]. Accordingly, concerted efforts have been 
extended by global pharmaceuticals to formulate new or improved antibiotics. 
However, despite high research cost-intensive investment in the last decade or so 
only two new classes of antibiotics have been introduced into the market [6, 7]. The 
imperative need for the uncovering of novel antimicrobial scaffolds has led to the 
resurgence of silver, however, in its nano-particulate form [8].
The antimicrobial activities of AgNPs are well established and currently 
researchers are striving to develop greener synthetic strategies for their production 
[1, 9]. The use of nanotechnology for the synthesis of AgNPs from environmentally 
compatible biomaterials is evolving into an important branch of science and tech-
nology [10]. To this end, a variety of biological extracts have been explored for the 
bottom-up synthesis of AgNPs [11]. However, there is an ongoing search to identify 
novel capping structures to produce AgNPs with increased bio-efficacies. In this 
context, this chapter points to highlight the use of plants as an alternative green 
technology for nanoparticle synthesis and their biomedical applications as potential 
biofactories for antibacterial, antifungal and anti-cancer agents.
2. Preparation of nanosilver
2.1 Conventional nanoparticle synthetic strategies
Established technologies for AgNP synthesis and other metal preparations can 
be categorised distinctly into two approaches, namely: “top to bottom”, which is 
normally employed by physicists and “bottom to up”, a construction favourite of 
chemists [12, 13]. Both approaches converge at the nanodimension but vary drasti-
cally in the synthetic technology. “Top to bottom” approaches apply various physi-
cal methods such as grinding, milling, sputtering, evaporation-condensation and 
thermal/laser ablation to break down bulk solid materials to their nanoparticulate 
form. “Bottom to up” approaches entail various chemical and biological methods to 
synthesise nanoparticles by the self-assembly of atoms such as Ag+ into nuclei that 
further develop into nano-sized particles [9].
Important physical “top to bottom” methods for nanoparticle preparation 
include evaporation-condensation and laser ablation techniques [14]. Evaporation-
condensation applies a tube furnace at atmospheric temperature wherein primary 
material (metal Ag) contained in a boat; is centred in the furnace and vaporised 
into a carrier gas [9]. Several inadequacies have been identified with this technique, 
for example, the furnace occupies a large space, requires high energy input whilst 
raising the environmental temperature around the source material and requires 
long durations to achieve thermal stability. Additionally, a major drawback to 
this type of synthesis is the resulting imperfections in the surface structure of the 
derived nanoparticles which can ultimately alter their physical properties [9, 15]. 
In laser ablation, irradiation is used to remove material from a bulk metal in solu-
tion. The efficacy of this technique and characteristics of nascent particles is largely 
dependent on a number of parameters including the wavelength of the laser, dura-
tion of laser pulses, laser fluence, ablation duration and the effective liquid medium 
with or without surfactants [16, 17]. An important advantage of laser ablation for 
AgNP preparation is the absence of chemicals in solution which could potentially 
contaminate the nanoparticle preparation [18].
Regarding “bottom to up” approaches, wet chemical reduction is the most fre-
quently practiced method for nanoparticle preparation [15] although, several other 
methods have been reported [19–22]. As the name suggests, wet chemical reduction 
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involves the reduction of a metal salt precursor in aqueous or organic solution. 
Various organic and inorganic compounds successfully utilised as reducing agents 
in the synthesis of AgNPs include: ascorbate; borohydride; citrate; elemental 
hydrogen; formaldehyde; N-N-dimethyl formamide (DMF); Tollen’s reagent; and 
polyethylene glycol blocks [15, 23, 24]. In addition to reducing agents, protective 
stabilising agents are also included in the reaction solution to prevent agglomeration 
of nascent nanoparticles [25, 26]. With stability achieved, this method can be useful 
to produce high nanoparticle yields with low preparation costs [27]. However, the 
efficacy of this method is challenged by the potential contamination of nascent 
nanoparticles by precursor chemicals, the use of toxic solvents and the generation 
of hazardous by-products [13, 28].
Evidently, the aforementioned physical and chemical methods have certain 
limitations that restrict their use in the preparation of nanoparticles for biological 
applications [29]. In this regard, concerted efforts have been extended to develop 
nanoparticle synthetic strategies that are environmentally sound. Essentially, this 
would entail the use of benign, biotechnological tools and has given rise to the 
concept of green technology. This technology can best be described as the use of 
biological routes such as plants and microorganisms or their byproducts in the 
synthesis of nanoparticles [29–31]. These bio-inspired methods (Figure 1) are not 
only environmentally welcoming but are cost effective and can be easily up-scaled 
for large productions [32].
2.2 Biological nanoparticle synthetic strategies
As previously eluded, biological approaches for AgNP synthesis employ the 
use of living organisms or their extracts as capping/reducing agents in a synthetic 
reaction. To date, a variety of biological entities have been explored for their Ag+ 
reducing abilities and include viruses, bacteria, plants, algae, fungi, yeast and mam-
malian cells [11, 13, 34–36]. Biological synthesis can be divided into two strategies, 
specifically: bioreduction and biosorption. Bioreduction occurs when metal ions 
undergo chemical reduction into biologically stable complexes. Many organisms 
have displayed dissimilatory metal reduction involving the coupling of reduction 
with oxidation of an enzyme. The resulting stable, inert nanoparticles can then be 
safely extracted from the reaction mixture. Alternatively, biosorption involves the 
attachment of metal ions onto an organism itself, such as on the cell wall. Various 
bacteria, fungi and plant species express peptides or possess modified cell wall 
structures that are capable of binding metal ions, thereby forming stable complexes 
in the form of nanoparticles [36].
In this review, the use of plant and bacterial biological material for AgNP 
synthesis will be discussed. For a review on the use of alternative biological entities 
as AgNP factories, studies by the following authors are recommended [11, 36, 37].
2.3 AgNP synthesis from plants
Plants have shown the capacity to hyper-accumulate metals as a means to 
protect themselves from insects and herbivores. This observation has paved way 
for the technology known as phytoextraction, wherein plants are employed to 
extract minerals from various groundwater and soil sediments. Major applica-
tions of phytoextraction include the mining of precious metals from unfeasible 
ground sites (phytomining), stabilisation or recovery of non-naturally occur-
ring contaminants (phytoremediation) and the addition of essential metals to 
growing crops. Interestingly, studies have unveiled that metals accumulated by 
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the plant are usually deposited in the form of nanoparticles. This has stimulated 
interest for the use of plants as factories for nanoparticle synthesis [35]. Whole 
plants have been explored for the synthesis of nanoparticles when grown on the 
appropriate metal enriched substrates. Species such as Brassica juncae (mustard 
greens) and Medicago sativa (alfalfa) have demonstrated the ability to accumulate 
AgNPs. For example, 50 nm sized AgNPs, at a high yield (13.6% of total plant 
weight) were reported for M. sativa when grown on silver nitrate (AgNO3) [38]. 
Additionally, icosahedral gold nanoparticles of 4 nm size were observed in M. 
sativa and semi-spherical copper nanoparticles of 2 nm size were observed in 
Iris pseudacorus when the plants were grown on gold and copper salt enriched 
 substrates, respectively [39, 40].
Although whole plants can potentially serve as factories for nanoparticle synthe-
sis, several disadvantages have been identified with this technology especially when 
up-scaling for industrial applications. For example, physical attributes of nanopar-
ticles such as size and shape vary upon the localisation of the particles in the 
plant due to the differences in metal ion content in different plant tissues and the 
possibility of nanoparticle movement and penetration [39]. This heterogeneity of 
important bioactivity-determinants such as size and shape [41, 42] limit the use of 
these nanoparticles and especially in applications where mono-dispersed nanopar-
ticle preparations are required. Furthermore, recovery of nanoparticles from living 
Figure 1. 
Different approaches for AgNP synthesis. Adapted from [9, 33].
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plants entails laborious extraction, isolation and purification procedures and may 
potentially result in low yields [35].
The use of plant broths/extracts in nanoparticle synthesis was introduced by 
Shankar et al., (2003). In their study, compounds responsible for the reduction of 
metal ions were extracted and used as reducing agents in a synthetic reaction mix-
ture, resulting in the extracellular production of nanoparticles [43]. This strategy 
tentatively offers several advantages compared to the use of whole plants. For exam-
ple, nanoparticle formation occurs considerably faster as opposed to whole plants 
which require diffusion of metal ions throughout the plant body. Additionally, the 
use of extracts would be more economical due to the ease of purification [35].
This in vitro approach has been actively developed and applied to a variety of plant 
flora for the synthesis of AgNPs [28]. Various organ extracts: stem, root, leaf, bark, 
fruit and fruit peel have demonstrated the ability to reduce Ag+. Particularly, biomol-
ecules (Figure 2) such as proteins, amino acids, enzymes, polysaccharides, alkaloids, 
tannins, phenolics, saponins, terpenoids and vitamins present in the extracts act as 
both reducing and stabilising agents [9].
Terpenoids are a class of diverse organic polymers manufactured in plants 
from five-carbon isoprene units and display strong antioxidant activities. In a 
previous study by Shankar et al., involving gold nanoparticle synthesis from 
geranium leaf extracts, it was suggested that these polymers were actively 
involved in the reduction of gold ions into stable nanoparticles [44]. Later Singh 
Figure 2. 
Major plant metabolites involved in the synthesis of metal nanoparticles: (A)-terpenoids (eugenol); (B & 
C)-flavonoids (luteolin, quercetin); (D)-a reducing hexose with the open chain form; (E & F)-amino acids 
(tryptophan, tyrosine). Adapted from [35].
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et al. reported that eugenol, the main terpenoid found in Szyygium aromaticum 
(clove), played an important role in reducing AgNO3 and HAuCL4. The Fourier 
transform infrared (FTIR) spectroscopy analysis of their study suggests that the 
dissociation of the proton from the OH group in eugenol leads to the formation 
of intermediate resonance structures which can undergo further oxidation. This 
latter reaction may be coupled to the reduction of Ag+ and subsequent formation 
of stable AgNPs [45].
Flavonoids are made up of a large group of polyphenolic compounds contain-
ing various classes such as anthocyanins, isoflavonoids, flavonols, chalcones, 
flavones and flavanones. There are several functional groups present on flavonoid 
compounds that can participate in nanoparticle formation. It has been hypoth-
esised that the tautomerization of flavonoids from the enol to keto form releases 
a reactive hydrogen atom that can participate in the reduction of metal ions. For 
example, studies involving AgNP synthesis from Ocimum sanctum extracts indi-
cate that synthesis is likely to be the result of tautomerization of the flavonoids 
luteolin and rosmarinic acid [46]. Additionally, some flavonoids can chelate 
metal ions with their carbonyl groups or π-electron. Quercetin is an example of 
a flavonoid with strong chelating activity [35]. These mechanisms may explain 
the prevalence of flavonoid groups adsorbed on to the surface of AgNPs derived 
in previous studies [47, 48]. Further indication of flavonoid involvement in 
nanoparticle synthesis is provided by a study using Lawsonia inermis, in which the 
flavonoid apiin was extracted and successfully employed in the synthesis of gold 
and Ag nanoparticles [49].
Sugars contained in plant extracts are also capable of inducing nanoparticle for-
mation. It is known that monosaccharides in the linear form containing an aldehyde 
(e.g. glucose), are capable reducing agents [35]. Monosaccharides harbouring a 
keto-group may act as antioxidants upon tautomeric transformation from a ketone 
to an aldehyde (e.g. fructose). In this regard, glucose is reportedly more efficient at 
metal ion reduction than fructose due to the kinetics of tautomerism from a ketone 
to an aldehyde which limits the reducing potential of fructose. Disaccharides and 
polysaccharides may also participate in the reduction of metal ions however, this is 
largely dependent on the ability of their monosaccharide components to take on an 
open chain configuration within an oligomer. Examples include lactose and malt-
ose. In contrast, sucrose is unable to participate in metal ion reduction because the 
linkage of its glucose and fructose monomers restrict the formation of open chains. 
However, when sucrose was placed in tetrachloroauric and tetrachloroplatinic acids, 
nanoparticle formation proceeded [50]. This may be due to the acidic hydrolysis of 
sucrose yielding glucose and fructose. In general, it is suggested that nanoparticle 
formation by sugars occurs by the oxidation of an aldehyde group into a carbonyl 
group which subsequently leads to the reduction of metal ions and nanoparticle 
formation [44].
FTIR analysis of plant derived metal nanoparticles have revealed the pres-
ence of proteins on their surface, suggesting that proteins may also possess metal 
ion reducing ability. However, amino acids have displayed differences in their 
potential for metal ion reducing and binding efficiencies. For example, lysine, 
cysteine, arginine and methionine have been shown to bind Ag+. In a separate 
study, aspartate was used to reduce tetrachloroauric acid forming nanoparticles, 
whilst valine and lysine did not possess this ability. Amino acids capable of 
binding metal ions are thought to do so through their amino or carboxyl groups 
or through side chain groups: carboxyl groups of aspartic and glutamic acid, 
imidazole ring of histidine, thiol of cysteine, thioether of methionine, hydroxyl 
group of serine; threonine and tyrosine, carbonyl groups of asparagine and 
glutamine [35].
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Linkage of amino acids in a peptide chain may also affect the ability of indi-
vidual amino acids to bind and reduce metal ions. For example, the R-carbon of 
amines and carboxylic acids in a peptide bond are inaccessible for association with 
metal ions. However, the free side chains of individual amino acids can still partici-
pate in binding and reduction of metal ions although, this is largely dependent on 
the amino acid sequence. Tan et al. demonstrated that synthesised peptides derived 
from amino acids with strong binding abilities and high reducing activities dis-
played lower reduction than expected [51]. A previous study suggested that protein 
molecules capable of nanoparticle formation display a strong attraction of metal 
ions to the regions on the molecule responsible for reduction however, their chelat-
ing activity is limited [52]. It was also suggested that the amino acid sequence of a 
protein can influence the size, shape and yield of derived nanoparticles. For exam-
ple, the synthetic peptide GASLWWSEKL was found to rapidly reduce metal ions 
forming a large number of small nanoparticles (˂10 nm), however, replacement of 
the N- and C- terminal residues forming the peptide SEKLWWGASL led to slower 
reduction and formation of larger nanospheres and nanotriangles (40 nm). These 
findings seemingly suggest that peptides and proteins present in plant extracts 
probably play a vital role in determining nanoparticle size and shape and potentially 
affect the overall yield of the nanoparticles [51].
2.4 AgNP synthesis from bacteria
There exists a vast array of literature pertaining to the use of bacteria as factories 
for nanoparticle synthesis [53, 54]. Bacteria have a marked advantage over other 
microbial systems such as fungi due to their abundance, rapid growth rate, cheap 
cultivation and the relative ease of their manipulation [55]. Their ubiquitous nature 
has led to their exposure and proliferation in many environmental extremes and 
ultimately depends on the natural defence mechanisms of these microorganisms to 
resist the effects posed by environmental stresses [56]. Bacteria have demonstrated 
these defence mechanisms in a few non-optimal growth conditions including 
environments contaminated with metal ions.
AgNP synthesis by bacteria can occur intracellularly or by the use of their 
extracts [53]. Several studies have reported intracellular synthesis by a variety 
of bacterial species and as similarly reported for the use of whole plants, this 
technology is associated with long duration periods for nanoparticle synthesis. 
For example, Pugazhenthiran et al. reported an incubation time of 7 days for 
AgNP synthesis from Bacillus sp. [57]. Kalimuthu et al. reported a reaction time of 
24 hours for AgNP synthesis by Bacillus licheniformis [58]. Although this reaction 
time was more industrially significant, the authors reported an additional extrac-
tion to acquire the derived nanoparticles. Synthesis of AgNPs by the use of bacte-
rial cell free supernatant (CFS) extracts was reported by Shahverdi et al., (2007). 
Interestingly, nanoparticle synthesis occurred within five minutes of Ag+ coming 
into contact with the CFS [59]. Thus, this method presents the greatest potential for 
industrial production of AgNPs from bacteria. Several other studies have reported 
on the production of AgNPs from bacterial CFS extracts but not at the previously 
stated formation rate [60, 61]. This seemingly suggests that bacterial extracts differ 
in their metal ion reducing abilities and may require an external energy source to 
accelerate nanoparticle formation.
2.4.1 Bacterial metabolites involved in nanoparticle synthesis
As previously stated, metal nanoparticle synthesis in bacteria may potentially 
occur through resistance mechanisms attained by these organisms to overcome the 
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toxic effects of metals. These strategies include redox state changes, efflux systems, 
intracellular precipitation, metal accumulation and extracellular formation of 
complexes (Figure 3) [56]. In an early study, Slawson et al. observed that the Ag 
resistant strain Pseudomonas stutzeri AG259, was capable of accumulating AgNPs 
(35–46 nm) within its periplasmic space. The formation of these nanoparticles 
was thought to have occurred by a mechanism involving the NADH-dependent 
reductase enzyme which undergoes oxidation to form NAD+. The lost free elec-
tron may potentially reduce Ag+ to AgNPs [62]. Later, He et al. reported that the 
NADH-dependent reductase enzyme may similarly participate in the extracellular 
formation of gold nanoparticles by the bacterium Rhodopseudomonas capsulata 
[63]. Other studies have reported nanoparticle formation without the use of 
biological enzymes. Non-enzymatic nanoparticle synthesis by a Corynebacterium 
sp. was reported by Sneha et al. [64]. Organic functional groups present at the cell 
wall were thought to induce metal ion reduction [64]. Sintubin et al. proposed a 
two-step mechanism for AgNP formation by several lactic acid bacteria, involving 
biosorption of Ag+ on the cell wall which is coupled to the subsequent reduction of 
these ions to form the nanoparticles [65]. Parikh et al. identified a gene homologue 
in a Ag-resistant Morganella strain with a 99% nucleotide sequence similarity 
to a periplasmic Ag-binding protein-encoding gene [66]. Johnston et al. further 
reported the production of a small non-ribosomal peptide, delftibactin by Delftia 
acidovorans which they believed to be associated with a resistance mechanism. 
By producing inert gold nanoparticles bound to delftibactin, gold ions no longer 
caused toxicity to the cells [67].
Figure 3. 
Metabolites and mechanisms involved in AgNP synthesis in bacteria: (a)-uptake of Ag+ and activation of 
reduction machinery; (b)-electron shuttle system involving various cofactors and enzymes; (c & d)- intra or 
extracellular localisation of AgNPs; (e)-electrostatic interaction between Ag+ and cell wall peptides/proteins & 
(f)-extracellular reduction by enzymes or other metabolites released in solution. Adapted from [53].
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3. Mechanism of nanoparticle synthesis using plants and microbes
There are three main phases in the synthesis of metal nanoparticles from plants 
and plant extracts. Initially, an activation phase takes place during which metal ions 
are reduced from mono or divalent oxidation states to zero-valent states, followed 
by nucleation of the reduced atoms. This step is immediately followed by a growth 
phase where small neighbouring nanoparticles coalesce into larger particles with 
greater thermodynamic stability while further biological reduction occurs. As 
growth proceeds nanoparticles aggregate to form various shapes such as: cubes, 
spheres, triangles, hexagons, pentagons, rods and wires [68]. Lastly, a termination 
phase follows in which nanoparticles acquire the most energetically favourable con-
formation, which ultimately determines the final shape of the particles (Figure 4) 
[69]. This step is largely influenced by the ability of the plant extract to stabilise 
the resulting nanoparticles. For example, the high surface energy of nanotriangles 
results in their decreased stability. Such nanoparticles would then acquire a more 
stable morphology such as a truncated triangle to minimise Gibbs free energy unless 
the stability is supported by the given extracts. It can be tentatively suggested that 
a similar mechanism occurs by the use of bacterial extracts since proteins and 
metabolites may also participate in Ag+ reduction as previously stated.
Several controlling factors affect the synthesis and morphology of derived 
nanoparticles. Several researchers have associated these variations with the choice 
of adsorbate and catalyst used in the synthetic process [29, 70]. However, reaction 
parameters have also been shown to strongly affect the synthesis of nanoparticles 
from biological extracts.
Studies have revealed that the pH of a reaction solution strongly influences the 
formation of the produced nanoparticles. Variances in reaction pH tend to induce 
variability in the shape and size of the produced nanoparticles. Lower acidic pH 
values tend to produce larger particles when compared to higher pH values. In a 
study employing Avena sativa (oat) biomass for the production of gold nanopar-
ticles, larger particles (25–85 nm) where formed at pH 2 whilst smaller particles 
(5–20 nm) were formed at pH 3 and 4 [71]. The researchers suggested that at 
pH 2, fewer functional groups were available for particle nucleation resulting in 
aggregation of the particles. A similar finding was observed in the synthesis of gold 
nanoparticles from the bacterium Rhodopseudomonas capsulate. At an increased pH 
of 7, spherical particles in the range of 10–20 nm in size were observed. In contrast, 
lowering the reaction pH to 4 resulted in the formation of nanoplates [63].
Temperature is an important factor in any synthesis. With respect to nanopar-
ticle formulation with the use of biological entities, temperature elevation has 
demonstrated catalytic behaviour by increasing the reaction rate and efficiency of 
nanoparticle formation. For example, a study on the influence of reaction tempera-
ture in the synthesis of AgNPs from neem leaf extracts suggested that temperature 
elevation (10–50°C) was correlated with enhanced reduction of Ag+ [72]. It was 
also noted that smaller sized AgNPs were produced at 50°C, similar to the finding 
of Kaviya et al. in the production of AgNPs from Citrus sinensis peel extracts using 
varying temperatures [73]. Similarly, this trend was observed in the production 
of AgNPs from the spent culture supernatants of Escherichia coli [61]. The authors 
tentatively suggested that the increased reaction rate might be because of tempera-
ture on a key enzyme participating in nanoparticle synthesis. However, the study 
importantly revealed that temperature elevation above 60°C contrastingly favoured 
the production of larger sized particles. The reason for this observation was 
reported as follows: at high temperatures, kinetic energy of the molecules increase 
resulting in rapid reduction of Ag+ (facilitating reduction and nucleation), to the 
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detriment of secondary reduction on the surface of nascent particles in the growth 
phase. However, higher temperatures beyond the optimum are thought to increase 
the growth of the crystal around the nucleus, resulting in the production of larger 
particles [48, 61].
Temperature has also been demonstrated to affect the structural form of 
nanoparticles. For example, AgNP synthesis using Cassia fistula extracts resulted 
in the formation of Ag nanoribbons at room temperature whilst spherical AgNPs 
Figure 4. 
Schematic representation of nanoparticle synthesis using a plant extract. Adapted from [35].
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were formed at temperatures above 60°C [74]. High temperatures in the study 
were thought to alter the interaction of plant biomolecules with the faces of Ag, 
 inhibiting the coalescence of adjacent nanoparticles.
Sunlight irradiation, a recently reported primary energy source for nanoparticle 
formation, has been observed to derive AgNPs with desired physical attributes. 
Recent studies on sunlight driven AgNP synthesis using Allium sativum (garlic 
extract) and Andrachnea chordifolia ethanol leaf extract revealed that sunlight 
rapidly enhanced nanoparticle formation to produce spherical AgNPs with average 
diameters of 7.3 nm and 3.4 nm, respectively [75, 76]. In addition, this use of sunlight 
has also been used in AgNP synthesis from Bacillus amyloliquefaciens CFS to produce 
circular and triangular crystalline AgNPs with an average diameter of 14.6 nm [77].
A variety of literature reports on the synthesis of AgNPs with differing mor-
phologies. Understanding the effects of these morphological characteristics on 
bioactivity is therefore an important consideration when deriving nanoparticles for 
therapeutic purposes. Characteristically, AgNPs are small (1–100 nm) and there-
fore possess a large surface area that facilitates their interaction with bacterial cell 
membranes [41, 78]. However, it has been suggested that within this confined size 
range, AgNPs present a size-dependent inhibition spectrum. Martinez-Castanon 
et al. reported that AgNPs of 7 nm in size had minimum inhibitory concentration 
(MIC) values of 6.25 μg ml−1 and 7.5 μg ml−1 for E. coli and Staphylococcus aureus, 
respectively. In contrast, larger nanoparticles (29 nm) capped with the same reduc-
ing agent displayed higher MIC values for the respective strains [79]. These results 
are in accordance with other studies that report nanoparticles of ˂ 10 nm in size 
display improved bactericidal activities [42, 80].
The interaction of AgNPs of varying shapes with E. coli cells has unveiled that 
shape plays an important factor in bioactivity. Pal et al. reported that at a low Ag 
content of 1 μg, truncated triangular nanoparticles showed nearly complete inhibi-
tion of E. coli cells, whilst spherical nanoparticles with a total silver content above 
12.5 μg displayed a reduction in colony forming units. Rod-shaped particles and 
AgNO3 presented inferior activities when compared to truncated triangular and 
spherically shaped AgNPs [41].
Considering these factors and the aforementioned factors affecting synthesis 
of nanoparticles, it can tentatively be suggested that the fine tuning of reaction 
parameters such as pH or temperature may be applied in producing AgNPs with 
these desired physical attributes. However, the use of sunlight irradiation provides a 
promising alternative in this regard.
3.1 Anti-microbial properties of silver nanoparticles
There exists an abundance of literature reporting on antimicrobial activities 
of biologically derived AgNPs [81–84]. Most of these studies utilise the disc dif-
fusion assay [85] or agar well diffusion assay [86] to establish inhibitory effects. 
Positive indication of inhibitory activities are visualised by zones of inhibition on a 
microbial lawn. Veersamy et al. reported zones of inhibition of S. aureus and E. coli 
to be 15 mm and 20 mm respectively for AgNPs (20 μg ml−1) derived from mango-
steen leaf extracts [48]. Similarly, Logeswari et al. reported zones of inhibition of 
AgNPs synthesised from various plant extracts against several bacterial strains [81]. 
Although diffusion techniques are preferred amongst researchers, they seem to be 
labour-intensive. In addition, many researchers do not establish the initial concen-
tration of AgNP solution prior to antimicrobial evaluation [82, 87]. Such disparities 
make comparison between published data inapplicable [88].
Determination of minimum inhibitory concentration (MIC) by the broth micro-
dilution or macrodilution method [89, 90] is easy to access and provides accurate 
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information with respect to microbial susceptibility. Moreover, MIC values are 
reported in various concentration units such as μg ml−1, μg l−1 or ppm thereby facili-
tating comparison between publications [53]. These methods are therefore attractive 
for AgNP bioactivity analysis. Furthermore, determination of MICs is an important 
consideration for any therapeutic agent in development to assess their toxicity at the 
specified concentration range. As previously mentioned, the antimicrobial effects 
of AgNPs are well established. However, a relatively confined amount of studies 
has been conducted to elucidate their mechanisms of antimicrobial action. These 
mechanisms are poorly understood and have failed to achieve consensus amongst 
researchers. Despite this, three common mechanisms of bactericidal activity have 
been proposed by various studies. These include the uptake of Ag+ (1), generation of 
reactive oxygen species (ROS) (2) and cell membrane disruption (3) (Figure 5) [91].
Since Ag+ are known to possess antibacterial activities, their release from AgNPs 
may potentially aid to the bioactivity of the nanoparticles. It is therefore fitting to 
consider the mechanistic action of Ag+ on bacterial cells.
The NADH–ubiquinone reductase has been established as one of the major 
targets for Ag+. Specifically, the binding of Ag+ to this enzyme may be responsible 
for their bactericidal effect even at minute concentrations [92]. Later, Dibrov et al. 
reported the binding of Ag+ to transport proteins leads to the leakage of protons 
and ultimately induces the collapse of the proton motive force [93]. Such interac-
tions with transport proteins may be attributed to the strong affinity of Ag+ to 
thiol groups found on cysteine residues of these molecules [94]. Ag+ has also been 
reported to inhibit phosphate uptake and additionally causes an efflux of intracellu-
lar phosphate [95]. It has also been hypothesised that the antimicrobial effect of Ag+ 
is correlated with the disruption of DNA replication. DNA molecules in a relaxed 
conformation can be replicated effectively. However, when Ag+ are present in bacte-
rial cells, DNA molecules enter a condensed form and replicating ability diminishes 
which ultimately leads to cell death [8].
Figure 5. 
Interactions of AgNPs with bacterial cells: (1) release of Ag+ and generation of ROS; (2) interaction with cell 
membrane proteins; (3) accumulation in cell membrane and disruption of permeability; (4) entry into the cell 
and release of Ag+, leading to generation of ROS and damage of cellular DNA. In turn, generated ROS may 
affect DNA, cell membrane and membrane proteins whilst released Ag+ may affect cell membrane proteins and 
DNA. Adapted from [91].
13
Green Synthesis of Metal Nanoparticles for Antimicrobial Activity
DOI: http://dx.doi.org/10.5772/intechopen.94348
The exposure of bacterial cells to AgNPs leads to the generation of ROS [96]. 
Naturally, ROS are metabolic by-products of respiring beings. Whist low levels of 
these species are skilfully controlled by various antioxidant defence mechanisms, 
high levels of ROS results in oxidative stress which is detrimental to any living 
organism. Metals can serve as catalysts and produce ROS in an oxygen containing 
environment [97]. AgNPs are therefore likely to catalyse reactions with oxygen 
leading to the production of excess free radicals. Kim et al. demonstrated the 
generation of free radicals from AgNPs by means of spin resonance measurements. 
Toxicity of AgNPs and AgNO3 diminished upon addition of an antioxidant suggest-
ing that the mechanism of action against bacterial strains was associated with the 
formation of free radicals from AgNPs. The generation of excess free radicals attack 
membrane lipids resulting in the breakdown of the membrane and cause damage to 
DNA [1].
The release of Ag+ from nanoparticles attached to the membrane and nanopar-
ticles inside the cell also play a role in the generation of ROS. Ag+ released on the 
membrane are capable of ROS generation by acting as electron acceptors whilst 
those present inside the cell more likely to interact with thiol groups of respiratory 
chain enzymes as previously stated, or scavenging superoxide dismutase enzymes 
[98]. The effect of ROS scavengers on E. coli cells was reported by Inoue et al.. 
Specifically, ROS such as superoxide anions, hydroxyl radicals, hydrogen peroxide 
and singlet oxygen contributed to the bactericidal activity against E. coli [99]. 
According to literature, the bactericidal effect of AgNPs may also be the result of 
damage to the outer membrane of bacterial cells. Previous studies by Sondi and 
Salopek-Sondi suggested that treatment of E. coli cells with AgNPs induced changes 
in the membrane morphology (Figure 6a). This resulted in increased membrane 
permeability and shifts in normal transport through the plasma membrane [100]. 
Morones et al. hypothesised that these mechanisms could explain the number of 
nanoparticles found inside E. coli cells (Figure 6b). AgNPs with oxidised surfaces 
were also reported to induce the formation of holes on the surface of E. coli cells and 
portions of the cellular surface were observed to be eaten away [101]. The attach-
ment and penetration of AgNPs has also been observed in P. aeruginosa (Figure 6c), 
V. cholera and S. typhus [80].
The mechanism of AgNP adhesion and penetration of bacterial cell membranes 
remains to be elucidated. Literature reports indicate that electrostatic interactions 
between positively charged particles and negatively charged cell membranes is 
essential for the bioactivity of these particles [102, 103]. However, this strategy does 
Figure 6. 
Transmission electron micrographs of (a) E. coli cell after 1 h treatment with 50 μg cm−3 AgNPs; (b) E. coli cell 




not validate the adhesion and penetration abilities of negatively charged nanopar-
ticles [104]. The researchers argued that although the particles were negatively 
charged, interactions between the particles and building elements of the membrane 
are likely to have occurred causing structural changes and degradation of the 
membrane. Morones et al. proposed that the interaction of AgNPs and bacterial 
membranes could be attributed to the strong affinity of the particles to sulphur 
containing proteins present on the membrane [80]. These interactions are thought 
to be conserved in the interaction of Ag+ and thiol groups on respiratory enzymes 
and transport proteins [80, 91].
Sondi and Salopek-Sondi [104] further reported that damage to E. coli cell 
membranes might also occur due to the incorporation of AgNPs into their mem-
brane structure. Scanning electron microscopy revealed the formation of “pits” on 
the surface of the membrane [100]. Similar findings were observed by [102]. Amro 
et al. [109] additionally reported the formation of irregularly shaped “pits” on 
the outer membrane of E. coli cells through the progressive release of lipopolysac-
charide molecules. This release of LPS molecules was induced by metal depletion in 
the cells [105]. A membrane with such morphological changes would display a high 
increase in permeability, rendering the cell incapable of regulating proper transport 
through the membrane as previously described.
Although these studies have been conducted on Gram-negative bacteria, AgNPs 
have also been reported to exert inhibitory activities against Gram-positive bacteria 
which differ from their counterparts based on differences in cell wall structure 
[106]. It can be tentatively suggested that AgNPs may form interactions with Gram-
positive bacteria through surface proteins present on the cell wall. Once penetrated, 
the mechanisms of bacterial activity are conserved with that of Gram-negative 
bacteria.
A relatively confined amount of literature focuses on the mechanisms of anti-
fungal activity exerted by AgNPs. However, based on the studies that have been 
reported, it seems that inhibition of fungal growth by AgNPs may be the result 
of damage to fungal cellular membranes. Kim et al. demonstrated the effect of 
AgNPs on Candida albicans. Transmission electron microscopy (TEM) analysis 
revealed that the treatment of cells with AgNPs lead to the formation of “pits” on 
the cell membrane which ultimately disrupts membrane potential [107]. A similar 
finding was made by Nasrollahi et al. who reported that AgNP incubation with 
C. albicans led to damage of the cell membrane [108]. Endo et al. reported that 
disruption of membrane integrity inhibits the normal budding process of daughter 
cells. Therefore, the authors suggested that AgNPs exert their inhibitory activ-
ity by inhibiting the budding of daughter cells due to the destruction of the cell 
 membrane [109].
AgNPs may also disrupt antioxidant defences in fungal cells. Eukaryotic cell 
studies suggest that AgNPs directly interact with gluthathione, gluthathione 
reductase or enzymes responsible for maintaining proper levels of gluthathione 
[110]. With respect to fungal cells, it has been hypothesised that Ag+ largely 
affect the function of membrane bound enzymes such as those in the respira-
tory chain. It has also been reported that exposure of fungal cells to Ag+ led to 
the loss of DNA replication ability. This results in the deactivation of ribosomal 
subunit protein expression and synthesis of non-functional enzymes and cellular 
proteins [111].
From these findings it can be tentatively suggested that bactericidal mechanisms 
of AgNPs are conserved in their inhibition of fungal cells. In summary, AgNPs exert 
their antimicrobial effects by releasing Ag+, disrupting the cell membrane/wall, 
generating ROS and inhibiting proper DNA replication.
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3.2 Cytotoxicity of silver nanoparticles
The unique physico-chemical and biological properties of AgNPs have extremely 
promising industrial and medical applications, as previously mentioned. However, 
there exists a dearth of knowledge regarding the effects of prolonged exposures to 
nanoparticles on human health and the environment [112]. It is therefore impera-
tive to establish the in vitro and in vivo cytotoxic effect of AgNPs in mind for 
therapeutic purposes.
3.2.1 In vivo studies
Human contact with nanoparticles occurs in the form of intravenous injection, 
oral administration, inhalation and dermal contact [113]. Injection of AgNPs in vivo 
results in short circulation times and broad tissue distribution. Target sites often 
include the liver (main target), spleen, lungs and kidneys [114]. Inhalation studies 
suggest that AgNPs become deposited in the olfactory mucosa and olfactory nerves 
which can potentially induce impairment and dysfunction of brain cells [115] in 
addition to immunotoxicity [116]. With regard to oral administration, migration 
of AgNPs to the gastrointestinal tract promotes dissolution of the particles which 
subsequently releases Ag+ [117]. A recent study on oral exposure to Ag+ indicated 
that these ions interact with sulphur leading to the formation of sulphur containing 
Ag granules in the intestinal epithelium [118]. The authors suggested that during 
intestinal digestion, Ag+ give rise to particle formation, possibly in the form of Ag2S 
or AgCl salt. They further added that this formation might influence their uptake 
and reduce the toxic effects of Ag+, however the effects of Ag salts on the intestine 
are yet to be elucidated [118, 119]. Reports on the exposure of workers to low doses 
of Ag dust indicated no significant changes in health status.
3.2.2 In vitro studies
Many researchers have demonstrated the cytotoxic effects of AgNPs in vitro, 
however there is still a lack of consistent and reliable data amongst publications. 
For example, in a recent review, Kim and Ryu (2013) attributed oxidative stress, 
apoptosis and genotoxicity to be the main in vitro outcome of AgNP exposure [120]. 
Later, Gliga et al. identified a major drawback of this review, highlighting that the 
AgNPs were different in each study, i.e. synthesised by different techniques, of 
varying size distributions and coatings, tested on different cell lines under differ-
ent cell culture conditions and often without the use of appropriate controls [121]. 
Additionally, Hackenberg et al. reported cytotoxicity of human mesenchymal 
stem cells at a concentration of 10 μg ml−1 AgNPs (˂50 nm), whereas Samberg et al.
reported no toxicity of progenitor human adipose-derived stem cells at concentra-
tions up to 100 μg ml−1 AgNPs (10–20 nm) [122, 123]. To determine the effect 
of size on cytotoxicity, Liu et al. compared the cytotoxicity of AgNPs ranging in 
size from 5 to 50 nm on four different cell lines (A549, HepG2, MCF-7 and CGC-
7901) and reported that 5 nm AgNPs were most toxic [124]. On the contrary, Kim 
et al. reported the enhanced release of lactate dehydrogenase (LDH) and reduced 
cell viability in the presence of 100 nm sized AgNPs when compared to smaller 
AgNPs (10–50 nm) [125]. It can be noted that the variation in parameters in these 
studies makes it difficult to observe trends and come to accurate assumptions. To 
achieve some consensus in this regard, Gliga et al. studied the cytotoxic effect of 
varying sized AgNPs capped by various agents on the normal bronchial epithelial 
cell line (BEAS-2B). They reported that 10 nm sized AgNPs induced cytotoxicity 
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irrespective of the capping agents, at high concentrations (20–50 μg ml−1), whilst 
larger AgNPs did not display significant cytotoxic effects at all tested concentra-
tions. The group additionally reported that at non-cytotoxic concentrations 
(10 μg ml−1), significant DNA damage was observed for all AgNPs independent of 
size and coating. In contrast, panda et al. reported no genotoxicity of AgNPs capped 
with protein at 20–80 μg ml−1 for 24–55 nm sized particles [126].
Overall, it is difficult to establish the cytotoxic effect of AgNPs due to the dif-
ferences in nanoparticle synthetic methods, their various sizes and capping agents 
and lastly the diverse evaluation tests used to determine toxicity. In fact, by using 
different organisms and/or culture cells there is no conclusive evaluation of AgNP 
toxicity [127]. However, bearing in mind the results presented in this review, it can 
be tentatively suggested that smaller sized AgNPs are more cytotoxic than larger 
sized particles at higher concentrations.
4. Potential applications of biologically derived nanoparticles
The physiochemical characteristics of metal nanoparticles render them applica-
ble across a genre of multi-disciplinary fields for a variety of uses including catalysis 
[128]; micro-electronics [129]; solar energy conversion [130] amongst many others 
[131]. They have also been recognised for their potential in a number of medical 
applications [132]. However, the use of nanoparticles derived from physical and 
chemical synthetic routes raises health and toxicity concerns due to the nature of 
the reaction conditions which may ultimately affect the properties of the derived 
particles [133].
Biologically derived nanoparticles provide a greener alternative to nanoparticles 
derived from the aforementioned routes since, the synthesis methods used to 
derive these particles are clean and non-toxic [9]. As a result, they are suitable for 
a number of biomedical applications (Table 1) including: cancer therapy; drug 
delivery; tumour detection; genetic disorder diagnosis; tissue repair; cell labelling; 
antimicrobial development; targeting and immunoassays and yet to be discovered 
applications [37, 114, 132, 134–136].
With respect to biologically derived AgNPs, their major exploitation exists in the 
development of antimicrobial agents due to their renowned microbial inhibitory 
activities and with the current status on antimicrobial drug resistance, these par-
ticles are being extensively sought after as possible alternatives to antibiotics [1, 8].
Plant Applications Reference
Moringa oleifera Anti-microbial [137]
Eclipta prostrata Anti-protozoal [138]
Gelidiella acerosa Anti-fungal [139]
Melia azedarach Anti-cancer [140]
Lampranthus coccineus Anti-viral [141]
Malephora lutea Anti-Alzheimer [142]
Melia azedarach Wound healing [143]
Ocimum sanctum Anti-diabetic [144]
Allium sativum Antioxidant [145]
Table 1. 
Selective applications of silver nanoparticles synthesised using plant extracts.
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5. Conclusion
In conclusion, it can be established that green synthetic strategies using plant 
and bacterial based extracts are promising alternatives to produce AgNPs. However, 
to produce AgNPs with enhanced bioactivities, morphological characteristics such 
as size and shape need to be finely tuned. Furthermore, the use of extracts with 
known medical value provides with attractive capping substrates that may poten-
tially enhance the bioactivities of the produced particles.
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